Morehouse School of Medicine News Center
-
Amerigroup Grants MSM $1.725 Million to Support Narrowing the Maternal Health Inequity Gap
FEBRUARY 21, 2022 - Program will support more than 127,000 pregnant and parenting Black women and their families across Georgia.
-
MSM Receives Nearly $9.7 Million Grant from HHS to Build COVID-19 Vaccine Confidence
FEBRUARY 15, 2022 - HealthWorks program aims to increase COVID-19 vaccine rates through targeted, culturally competent outreach efforts in Georgia and Tennessee.
-
MSM and UGA Win NIH Grant to Study Environmental Health in Underrepresented Communities
FEBRUARY 9, 2022 - Frontiers in Environmental Science and Health (FrESH) program to train and mentor researchers and healthcare professionals
-
MSM Partners with the City of East Point, Georgia to Advance Health Equity Through Policy
FEBRUARY 8, 2022 - Health experts, policy makers, and community organizations partner to address policies that perpetuate health disparities
-
MSM Microbiologist Awarded NIH Grant to Develop New Intervention Against Cerebral Malaria
FEBRUARY 7, 2022 - $2.7 million grant to fund international team to research potential treatment for severe malaria which kills approximately 500,000 children annually.
-
Research Finds COVID Pandemic Worsened Health Equity Gap
FEBRUARY 1, 2022 - National survey conducted by the Morehouse School of Medicine and Teva Pharmaceuticals shows intensified impacts among vulnerable populations driven by lack of access to care.
-
-
MSM Research Leader James Lillard, PhD, MBA Elected to 2021 class of AAAS Fellows
JANUARY 26, 2022 - Noted program highlights innovation in science and research
-
MSM Awarded $10,000 Gift from HBCU Change and Asbury Automotive Group
JANUARY 25, 2022 - Innovative philanthropic technology company and leading automotive retailer partner to support HBCUs
-
An Inter-Faith Alliance to Stop COVID-19
JANUARY 20, 2022 - Georgia CEAL is a member of the National Institutes of Health that supports statewide efforts to conduct urgent community-engaged research and outreach focused on COVID-19 awareness and education to address misinformation and mistrust; and promote and facilitate inclusion of diverse racial and ethnic populations in clinical trials (prevention, vaccine, therapeutics), reflective of the populations disproportionately affected by the pandemic.